Shian‐Ren Lin
- Molecular Biology
- Pharmacology top 10%
- Oncology
- Biotechnology top 5%
- Endocrinology, Diabetes and Metabolism top 10%
- Co-authors
- Ching‐Feng WengMax K. LeongPing‐Jyun SungHenrich ChengMay‐Jywan TsaiChe‐Fang HsuJian‐Chyi ChenYaw‐Syan Fu
- Topics
- Microbial Metabolism and Applications (6 papers)Prostate Cancer Treatment and Research (5 papers)Tannin, Tannase and Anticancer Activities (4 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Shian‐Ren Lin
25 papers receiving 908 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Biology 399
- Pharmacology 143
- Oncology 130
- Biotechnology 125
- Endocrinology, Diabetes and Metabolism 117
Countries citing papers authored by Shian‐Ren Lin
This map shows the geographic impact of Shian‐Ren Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shian‐Ren Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shian‐Ren Lin more than expected).
Fields of papers citing papers by Shian‐Ren Lin
This network shows the impact of papers produced by Shian‐Ren Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shian‐Ren Lin. The network helps show where Shian‐Ren Lin may publish in the future.
Co-authorship network of co-authors of Shian‐Ren Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Shian‐Ren Lin. A scholar is included among the top collaborators of Shian‐Ren Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shian‐Ren Lin. Shian‐Ren Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 5 | |
| 3 | 22 | |
| 4 | 38 | |
| 5 | 11 | |
| 6 | 10 | |
| 7 | 37 | |
| 8 | 8 | |
| 9 | 33 | |
| 10 | 22 | |
| 11 | 8 | |
| 12 | 46 | |
| 13 | 17 | |
| 14 | Natural compounds as potential adjuvants to cancer therapy: Preclinical evidencebreakdown → | 304 |
| 15 | 41 | |
| 16 | 30 | |
| 17 | 30 | |
| 18 | 120 | |
| 19 | 30 | |
| 20 | 34 |
About Shian‐Ren Lin
Shian‐Ren Lin is a scholar working on Applied Microbiology and Biotechnology, Biotechnology and Endocrinology, Diabetes and Metabolism, having authored 25 papers that have together received 915 indexed citations. Recurring topics across this work include Microbial Metabolism and Applications (6 papers), Prostate Cancer Treatment and Research (5 papers) and Tannin, Tannase and Anticancer Activities (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (41 citations), Biotechnology (125 citations) and Pharmacology (114 citations). Shian‐Ren Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Ching‐Feng Weng, Max K. Leong, Ping‐Jyun Sung, Henrich Cheng, May‐Jywan Tsai, Che‐Fang Hsu, Jian‐Chyi Chen, Yaw‐Syan Fu, Henrich Cheng and Yu‐Hsin Chen. Their work appears in journals such as Oncogene, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.